back
Food Allergy Essentials
Common Allergens
Food Allergy 101
Allergy Alerts & Ingredient Notices
Back to School Headquarters
Food Allergy & Anaphylaxis Emergency Care Plan
Recipes
Free Downloadable Resources
Shop Sifter
Information for you
Newly Diagnosed
Children with Food Allergies
Adolescents and Teens
Adults with Allergies
Educators
Healthcare Providers
College Staff
Other Professionals
Join the Community
Join the FARE Community
Find a Support Group

back
Accelerating Innovation
Elevating Care
Pioneering Advances in Diagnosis
Early Introduction and Food Allergy Prevention
Developing Effective Treatments
Elevating Research
FARE Patient Registry
FARE Clinical Network
FARE Data Coordinating Center
FARE Biobank
Clinical Trials
Recently Funded Research
Research Funding Opportunities

Media Room

Releases & Statements

Statement from Sung Poblete, PhD, RN, CEO of FARE, on Advancement in the House Toward Adding Peanut-Containing Foods to WIC Food Packages for Infants

July 11, 2024

Statement from Sung Poblete, PhD, RN, CEO of FARE on EURneffy Adrenaline Nasal Spray, Recommended for Approval in the EU

June 28, 2024

Statements from FARE following the FDA issuing a warning letter to Bimbo Bakeries USA, Inc.

June 25, 2024

Statement from Sung Poblete, PhD, RN, CEO of FARE on Mars' New Campaign to Increase Consumption of Snickers Bars on Flights

June 24, 2024

Timeline and Statements by FARE and Sung Poblete, PhD, RN, CEO of FARE, Regarding Public Assertion Made by Lynsi Snyder, Owner and President of In-N-Out Burger

June 20, 2024

Statement by Sung Poblete, PhD, RN, CEO of FARE, Regarding Public Assertion Made by Lynsi Snyder, Owner and President of In-N-Out

June 15, 2024

EpiPen Price Cap Bill Passes New York Legislature – EpiPens to Cost $100

June 04, 2024

Once signed into law, FARE-Led Effort Will Benefit the Two Million New Yorkers with Food Allergies Starting Jan. 1, 2026

Public Venues to Be Safer for New York’s Two Million Food Allergy Families

May 30, 2024

FARE-Championed Bill Passes NY State Legislature. Once signed, New York public venues for 1,000+ people to have epinephrine auto-injectors available.

FARE Announces Recipients of $1 Million in Grant Funding for Research Related to Food Protein-Induced Enterocolitis Syndrome (FPIES)

May 29, 2024

FPIES is a less-researched food allergy disease that affects an estimated 900,000 people in the U.S.

Statement by Sung Poblete, PhD, RN, CEO of FARE, Regarding Uber Eats New Feature for Food Allergy Consumers

May 28, 2024

Food Allergy Research and Education (FARE) and CVS Pharmacy Announce HALO Award for the Teal Pumpkin Project Campaign

May 16, 2024

The Teal Pumpkin Project promotes safety and inclusion for those managing food allergies during Halloween

FARE Thanks Congress and Advocates for Making Airlines Safer

May 15, 2024

Food Allergy Community to Benefit from New Federal Aviation Administration (FAA) Reauthorization

Media Contact:

media@foodallergy.org.

About FARE

FARE (Food Allergy Research & Education) is the leading nonprofit organization that empowers the food allergy patient across the journey of managing their disease. FARE delivers innovation by focusing on three strategic pillars—advocacy, research, and education—united by the through line of health equity. FARE’s initiatives accelerate the future of food allergy through effective policies and legislation, novel strategies toward prevention, diagnosis, and treatment, and building awareness and community. For more information, visit FoodAllergy.org.